Industry: Other Health Care (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-08-05 | New | $4,247,670 | $4,247,670 | Equity Only | 06b | SEC link |
2024-05-23 | New | $46,999,682 | $46,999,682 | Equity Only | 06b | SEC link |
2023-01-04 | New | $86,616,156 | $86,616,156 | Equity Only | 06b | SEC link |
2021-08-05 | New | $17,671,749 | Unknown | Equity Only | SEC link | |
2019-08-19 | New | $6,238,140 | $6,238,140 | Equity Only | 06b | SEC link |
2018-01-29 | New | $10,999,314 | $10,999,314 | Equity Only | 06b | SEC link |
2015-07-17 | New | $1,805,951 | $1,805,951 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Matthew Aprahamian | Director |
Christopher Brandt | Director |
Chistopher Brandt | Director |
Mark Buffington | Director |
Paul Iaffaldano | Director |
Guljit Khurana | Executive |
Sever Totia | Director |
Anil Vinayak | Executive |
Todd Walrath | Director, Executive, Promoter |
E. Todd Walrath | Director, Executive |